What is the ticker symbol for Aptinyx?

Aptinyx trades under the ticker APTX on NASDAQ.

What sector does Aptinyx operate in?

Aptinyx is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze APTX in a portfolio?

PortView shows APTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Aptinyx (APTX) Stock Analysis

NASDAQHealthcareBiotechnology

$0.10+3.17%

1-year price historyRange $0.05 – $0.69

52-week range$0.10

$0.01$0.72

What Aptinyx does

Aptinyx Inc. is a biopharmaceutical company in the clinical development stage, focused on identifying, advancing, and commercializing innovative, proprietary, synthetic small-molecule therapies for neurological and central nervous system disorders. Its primary drug candidate, NYX-2925, is currently in Phase II clinical trials for addressing painful diabetic peripheral neuropathy, and also in Phase IIb evaluation for fibromyalgia. Additionally, the company is developing NYX-783, an N-methyl-D-aspartate receptor (NMDAr) modulator, which is undergoing Phase IIb clinical trials for post-traumatic stress disorder (PTSD). Another NMDAr modulator, NYX-458, is in Phase II clinical study, targeting cognitive impairment related to Parkinson's disease. Aptinyx Inc. also holds a research collaboration agreement with Allergan plc. The company was founded in 2015 and is based in Evanston, Illinois.

Key metrics

Market cap

P/E (TTM)

-0.10

EPS (TTM)

$-0.98

Beta

1.22

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.07

200-day avg

$0.08

52-week high

$0.72

52-week low

$0.01

CEO

Craig R. Jalbert CIRA

ETFs linked to APTX

Broad-market and Healthcare sector ETFs an investor holding Aptinyx is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how APTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze APTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Aptinyx?: Aptinyx trades under the ticker APTX on NASDAQ.
Which exchange is APTX listed on?: APTX is listed on NASDAQ.
What sector does Aptinyx operate in?: Aptinyx is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze APTX in a portfolio?: PortView shows APTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.